Wedbush Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Wedbush Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,495	Closed	-$329K	–	1171
2025 Q2	$329K	Sell	13,495 -1,245	-8%	-$27.3K	0.01%	794
2025 Q1	$306K	Buy	+14,740	New	+$370K	0.01%	805
2022 Q2	–	Sell	-4,724	Closed	-$217K	–	1075
2022 Q1	$217K	Buy	4,724 +135	+3%	+$6.44K	0.01%	949
2021 Q4	$281K	Sell	4,589 -2,508	-35%	-$173K	0.01%	899
2021 Q3	$530K	Buy	7,097 +3,786	+114%	+$318K	0.03%	586
2021 Q2	$306K	Sell	3,311 -25	-0.7%	-$2.13K	0.01%	854
2021 Q1	$296K	Buy	+3,336	New	+$331K	0.02%	819

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wedbush Securities's ARKG Position: Q3 2025 in Review

Wedbush Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 13,495 shares — an estimated $329K sold.

Wedbush Securities first reported a position in ARKG in Q1 2021 and held it in 7 quarters. The position peaked at $530K in Q3 2021. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

Wedbush Securities reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
Wedbush Securities sold 13,495 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $329K.
Wedbush Securities first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 7 quarters.
Wedbush Securities's ARK Genomic Revolution ETF position peaked at $530K in Q3 2021.
231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Wedbush Securities's 13F filing for Q3 2025, filed 6 Nov 2025.